NC Political News Daily Briefs
Today’s briefs cover AI oversight proposals, generic-drug restitution and public comment on flood resilience plans.
Today’s briefs cover AI oversight proposals, generic-drug restitution and public comment on flood resilience plans.
North Carolina borrowers are slated to receive about $7.5 million in debt relief and nearly $2 million in restitution under a multistate auto-lending settlement.
North Carolina Attorney General Jeff Jackson is leading a bipartisan coalition seeking stronger federal verification, monitoring and enforcement requirements for companies that carry telephone calls.
Attorney General Jeff Jackson is seeking nearly $600,000 in restitution and more than $1.1 million in civil penalties in the Holly Christina Photography case.
North Carolina joined the Federal Trade Commission and 21 other states in a lawsuit alleging Amazon manipulated advertising auctions and overcharged businesses by more than $20 billion.
North Carolina is slated to receive at least $451 million, and up to $645 million, under a multistate Meta settlement announced by Attorney General Jeff Jackson.
Opening arguments began in a multistate case in which North Carolina and other states accuse Meta of designing addictive platforms for children and misleading the public.
Some North Carolina consumers are expected to receive payments from a $700 million Google Play Store antitrust settlement.
North Carolina has joined a proposed $400 million settlement with Sandoz over allegations involving prices and competition for generic prescription drugs.
Fifty attorneys general are asking federal regulators to require stronger customer screening and monitoring by voice-service providers.
North Carolina consumers and state payors will receive more than $700,000 through a $29.6 million multistate settlement with Glenmark over generic drug price-fixing allegations.
North Carolina consumers and state payors will receive more than $700,000 through a multistate settlement resolving generic-drug price-fixing allegations against Glenmark Pharmaceuticals.